Role in the diagnosis of coronary heart disease (CHD)
Holter monitoring is an essential component of a comprehensive cardiac workup. In confirmed stable CHD, if the attending physician has a clinical suspicion of concomitant cardiac arrhythmias, ambulatory monitoring becomes a mandatory diagnostic step. This clinical guideline has the highest level of recommendation (ESC I C, LOR B, LOE 2).
The method is of particular importance when interpreting the pre-test probability (PTP) of CHD. The results of Holter ECG (ordered strictly according to indications) are analyzed exclusively in conjunction with other primary screening data. The basic diagnostic workup includes:
- Carefully collected medical history and physical examination results.
- Data from a wide range of laboratory tests.
- Standard resting 12-lead ECG recording.
- Resting echocardiography (EchoCG).
- Chest radiography (if indicated).
The combined analysis of these primary data, supplemented by exercise ECG results and assessment of coronary calcification using computed tomography (CT), allows the physician to calculate the modified pre-test probability. It is based on this comprehensive conclusion that a decision is made regarding the need to confirm the diagnosis using specific non-invasive or invasive tests with high sensitivity.
Monitoring in dilated cardiomyopathy (DCM)
Patients with a confirmed diagnosis of DCM are strongly advised to undergo 24-hour Holter ECG monitoring. In this clinical situation, a standard resting ECG, echocardiography, or exercise testing cannot replace the Holter study. The method addresses three key tasks simultaneously (level of recommendation IIaC, C, 5):
- Analysis of baseline parameters: precise continuous assessment of the baseline rhythm and heart rate (HR) over 24 hours.
- Detection of hidden pathologies: reliable identification of transient rhythm disturbances and episodes of cardiac conduction abnormalities.
- Pharmacological control: objective assessment of the efficacy and safety of the patient's prescribed antiarrhythmic therapy.
It is important to note that in the context of 24-hour ECG monitoring in cardiomyopathies, the focus of attention is specifically on evaluating antiarrhythmic drugs. Monitoring anticoagulant, antihypertensive, or antianginal therapy requires different diagnostic approaches and laboratory tests.
Management algorithm in arterial hypertension and hypercorticism
In clinical practice, situations frequently arise where arterial hypertension (AH) persists in patients despite adequately selected and regular treatment. This resistant course often develops as part of iatrogenic hypercorticism, particularly in patients with the hypertensive form of congenital adrenal hyperplasia (HF CAH).
For timely diagnosis and correction of macrovascular complications of AH in this complex category of patients, a specialized evaluation algorithm is applied:
- Specialist: regular follow-up is performed by a cardiologist.
- Frequency of evaluation: instrumental screening is performed at least once a year.
- Instrumental methods (strictly according to indications): baseline ECG, echocardiography (EchoCG), ambulatory blood pressure monitoring (ABPM), and 24-hour Holter ECG monitoring.
The comprehensive application of these methods makes it possible to promptly detect pathological changes in target organs and adjust the therapeutic tactics.
The 'RAO' rule for Holter purposes in DCM: R — Rhythm and HR (assessment), A — Arrhythmias and blocks (search for transients), O — Optimization of therapy (antiarrhythmic).
Class and exam questions
In what cases is 24-hour monitoring mandatory for CHD?
The method is indicated for patients with proven stable coronary heart disease who are clinically suspected of having concomitant cardiac arrhythmias.
Does Holter monitoring replace exercise tests?
No, these methods complement each other. Holter monitoring is part of the primary workup, while exercise ECG is used to clarify the diagnosis and modify the pre-test probability of the disease.
How often should monitoring be performed in complicated AH associated with hypercorticism?
According to the evaluation algorithm, instrumental screening (including Holter, EchoCG, and ABPM as indicated) should be prescribed by a cardiologist at least once a year.
Which therapy is evaluated using Holter ECG in patients with DCM?
In dilated cardiomyopathy, ambulatory monitoring is used exclusively to monitor the efficacy and safety of antiarrhythmic therapy (rather than antihypertensive or anticoagulant therapy).
What else to study on this topic
- Strategies for assessing and modifying the pre-test probability (PTP) of CHD
- Differential diagnosis of transient rhythm and conduction disorders
- Assessment of coronary calcification (CT) in cardiology practice
- Instrumental diagnostics of macrovascular complications of arterial hypertension
- Management algorithms for patients with iatrogenic hypercorticism and HF CAH
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Full textbook on '24-hour Holter ECG monitoring' and 2,199 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.